Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 12, 1999, Pages 2975-2983

  Westbrock Wadman, Shannon ^b   Sherman, David R ^a,b   Hickey, Mark J ^b   Coulter, Silvija N ^b   Zhu, Ya Qi ^b   Warrener, Paul ^b   Nguyen, Lisa Y ^b   Shawar, Ribhi M ^b   Folger, Kim R ^b   Stover, C Kendall ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM MUTANT; ESCHERICHIA COLI; GENE EXPRESSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032762778     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.12.2975     Document Type: Article

References (51)

1. Aires, J. R., and P. Plesiat. 1998. mexGH, a new multidrug active efflux operon in Pseudomonas aeruginosa GenBank accession no. AF073776. (Unpublished [direct submission to GenBank].)
2. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
3. Bryan, L. E., R. Haraphongse, and H. M. Van den Elzen. 1976. Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification. J. Antibiot. 29:743-753.
4. Bryan, L. E., and S. Kwan. 1981. Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport. Antimicrob. Agents Chemother. 19:958-964.
5. 552 and nitrate reductase. Antimicrob. Agents Chemother. 17:71-79.
6. Bryan, L. E., K. O'Hara, and S. Wong. 1984. Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:250-255.
7. Bukanov, N., V. N. Ravi, D. Miller, K. Srivastava, and D. E. Berg. 1994. Pseudomonas aeruginosa corneal ulcer isolates distinguished using the arbitrarily primed PCR DNA fingerprinting method. Curr. Eye Res. 13:783-790.
8. Cherepanov, P. P., and W. Wackernagel. 1995. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158:9-14.
9. Enderle, P. J., and M. A. Farwell. 1998. Electroporation of freshly plated Escherichia coli and Pseudomonas aeruginosa cells. BioTechniques 25:954-958.
10. Evans, K., and K. Poole. 1999. The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated. FEMS Microbiol. Lett. 173:35-39.
11. Fralick, J. A. 1996. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J. Bacteriol. 178:5803-5805.
12. Gautom, R. K. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J. Clin. Microbiol. 35:2977-2980.
13. Hancock, R. E. Personal communication.
14. Hancock, R. E. 1998. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin. Infect. Dis. 27(Suppl. 1):S93-S99.
15. Hasegawa, M., I. Kobayashi, T. Saika, and M. Nishida. 1997. Drug-resistance patterns of clinical isolates of Pseudomonas aeruginosa with reference to their lipopolysaccharide compositions. Chemotherapy 43:323-331.
16. Hickey, M. J. Unpublished data.
17. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.
18. Kohler, T., M. Michea-Hamzehpour, U. Henze, N. Gotoh, L. K. Curty, and J. C. Pechere. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:345-354.
19. Li, X. Z., and K. Poole. Inverse relationship between MexAB-OprM expression and expression of MexCD-OprJ and MexEF-OprN multidrug efflux systems of Pseudomonas aeruginosa, ahstr. 21. In Program and abstracts of the ASM Conference on Pseudomonas '99: Biotechnology and Pathogenesis. American Society for Microbiology, Washington, D.C.
20. Lisitsyn, N., N. Lisitsyn, and M. Wigler. 1993. Cloning the differences between two complex genomes. Science 259:945-951.
21. Lloyd, A. M., and R. W. Davis. 1994. Functional expression of the yeast FLP/FRT site-specific recombination system in Nicotiana tabacum. Mol. Gen. Genet. 242:653-657.
22. Lomovskaya, O., A. Lee, K. Hoshino, H. Ishida, A. Mistry, M. S. Warren, E. Boyer, S. Chamberland, and V. J. Lee. 1999. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1340-1346.
23. MacLeod, D. L., L. E. Nelson, R. M. Shawar, B. B. Lin, L. G. Lockwood, J. E. Dirks, G. H. Miller, J. L. Burns, and R. L. Garber. Aminoglycoside resistance mechanisms for Pseudomonas aeruginosa strains in cystic fibrosis patients are unchanged by chronic treatment with inhaled tobramycin. Submitted for publication.
24. Miller, G. H., F. J. Sabatelli, L. Naples, R. S. Hare, and K. J. Shaw. 1994. Resistance to aminoglycosides in Pseudomonas. Aminoglycoside Resistance Study Groups. Trends Microbiol. 2:347-353.
25. Miller, G. H., F. J. Sabatelli, L. Naples, R. S. Hare, and K. J. Shaw. 1995. The most frequently occurring aminoglycoside resistance mechanisms - combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups. J. Chemother. 7(Suppl. 2):17-30.
26. Mine, T., Y. Morita, A. Kataoka, T. Mizushima, and T. Tsuchiya. 1999. Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:415-417.
27. Moore, R. A., D. DeShazer, S. Reckseidler, A. Weissman, and D. E. Woods. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465-470.
28. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Document M2-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
29. National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial susceptibility testing, Eighth informational supplement. Document M100-S8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
30. National Center for Biotechnology Information Website. 13 October 1999, revision date. [Online.] National Institutes of Health, Bethesda, Md. http://www.ncbi.nim.nih.gov. [27 October 1999, last date accessed.]
31. Nicas, T. I., and R. E. Hancock. 1980. Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J. Bacteriol. 143:872-878.
32. Nikaido, H. 1998. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin. Infect. Dis. 27(Suppl. 1):S32-S41.
33. Ocaktan, A., H. Yoneyama, and T. Nakae. 1997. Use of fluorescence probes to monitor function of the subunit proteins of the MexA-MexB-oprM drug extrusion machinery in Pseudomonas aeruginosa. J. Biol. Chem. 272:21964-21969.
34. Paulsen, I. T., J. H. Park, P. S. Choi, and M. H. Saier, Jr. 1997. A family of gram-negative bacterial outer membrane factors that function in the export of proteins, carbohydrates, drugs and heavy metals from gram-negative bacteria. FEMS Microbiol. Lett. 156:1-8.
35. Phillips, I., A. King, and K. Shannon. 1986. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study. Am. J. Med. 80:48-55.
36. Poole, K., N. Gotoh, H. Tsujimoto, Q. Zhao, A. Wada, T. Yamasaki, S. Neshat, J. Yamagishi, X. Z. Li, and T. Nishino. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21:713-724.
37. Poole, K., K. Tetro, Q. Zhao, S. Neshat, D. E. Heinrichs, and N. Bianco. 1996. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother. 40:2021-2028.
38. Poxton, I. R., G. T. Bell, and G. R. Berdlay. 1985. The association on SDS-polyacrylamide gels of lipopolysaccharide and outer membrane proteins of Pseudomonas aeruginosa as revealed by monoclonal antibodies and Western blotting. FEMS Microbiol. Lett. 27:247-251.
39. Price, K. E., P. A. Kresel, L. A. Farchione, S. B. Siskin, and S. A. Karpow. 1981. Epidemiological studies of aminoglycoside resistance in the U.S.A. J. Antimicrob. Chemother. 8(Suppl. A):89-105.
40. Saier, M. H., Jr., R. Tam, A. Reizer, and J. Reizer. 1994. Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport. Mol. Microbiol. 11:841-847.
41. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
42. Schweizer, H. P. 1998. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob. Agents Chemother. 42:394-398.
43. Schweizer, H. P., and T. T. Hoang. 1995. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene 158:15-22.
44. Shaw, K. J., R. S. Hare, F. J. Sabatelli, M. Rizzo, C. A. Cramer, L. Naples, S. Kocsi, H. Munayyer, P. Mann, G. H. Miller, et al. 1991. Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob. Agents Chemother. 35:2253-2261.
45. Shimizu, K., T. Kumada, W.-C. Hsieh, H.-Y. Chung, Y. Chong, R. S. Hare, G. H. Miller, F. J. Sabatelli, and J. Howard. 1985. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob. Agents Chemother. 28:282-288.
46. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
47. Vogel, H. J., and D. M. Bonner. 1956. Acetylornithinase of Escherichia coli: partial purification and some properties. J. Biol. Chem. 218:97-106.
48. West, S. E., H. P. Schweizer, C. Dall, A. K. Sample, and L. J. Runyen-Janecky. 1994. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148:81-86.
49. Wong, K. K., K. Poole, N. Gotoh, and R. E. Hancock. 1997. Influence of OprM expression on multiple antibiotic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2009-2012.
50. Yoneyama, H., K. Sato, and T. Nakae. 1991. Aminoglycoside resistance in Pseudomonas aeruginosa due to outer membrane stabilization. Chemotherapy 37:239-245.
51. Young, M. L., M. Bains, A. Bell, and R. E. Hancock. 1992. Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniques. Antimicrob. Agents Chemother. 36:2566-2568.